Univercells Technologies Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
68
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Univercells Technologies General Information
Description
Manufacturer of bioprocess technologies intended for the production of viral vaccines and viral vectors. The company provides intensified fixed-bed bioreactors and automated upstream platforms, enabling cell and gene therapy manufacturers to achieve cost-effective and scalable manufacturing of high-quality therapies with a reduced footprint.
Contact Information
Website
www.univercellstech.com(Operating Subsidiary)
Corporate Office
- Avenue Herrmann-Debroux 54
- Chemin de la Vieille Cour 56a & 56b
- 1400 Nivelles
- Belgium
Corporate Office
- Avenue Herrmann-Debroux 54
- Chemin de la Vieille Cour 56a & 56b
- 1400 Nivelles
- Belgium
Univercells Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Univercells Technologies Comparisons
Industry
Financing
Details
Univercells Technologies Competitors (13)
One of Univercells Technologies’s 13 competitors is Vir Biotechnology, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA | ||||
| Araris | Formerly VC-backed | Zurich, Switzerland | ||||
| Diagenode | Formerly VC-backed | Seraing, Belgium | ||||
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD | ||||
| Complete Genomics | Formerly VC-backed | San Jose, CA |
Univercells Technologies Signals
Univercells Technologies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Univercells Technologies FAQs
-
When was Univercells Technologies founded?
Univercells Technologies was founded in 2013.
-
Where is Univercells Technologies headquartered?
Univercells Technologies is headquartered in Nivelles, Belgium.
-
What is the size of Univercells Technologies?
Univercells Technologies has 68 total employees.
-
What industry is Univercells Technologies in?
Univercells Technologies’s primary industry is Biotechnology.
-
Is Univercells Technologies a private or public company?
Univercells Technologies is a Private company.
-
What is the current valuation of Univercells Technologies?
The current valuation of Univercells Technologies is .
-
What is Univercells Technologies’s current revenue?
The current revenue for Univercells Technologies is .
-
How much funding has Univercells Technologies raised over time?
Univercells Technologies has raised $53.1M.
-
Who are Univercells Technologies’s investors?
Gamma Biosciences and Univercells have invested in Univercells Technologies.
-
Who are Univercells Technologies’s competitors?
Vir Biotechnology, Araris, Diagenode, Personal Genome Diagnostics, and Complete Genomics are some of the 13 competitors of Univercells Technologies.
-
When was Univercells Technologies acquired?
Univercells Technologies was acquired on 29-Jun-2023.
-
Who acquired Univercells Technologies?
Univercells Technologies was acquired by Donaldson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process